within Pharmacolibrary.Drugs.ATC.L;

model L01FF07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1.0,
    Cl             = 0.00013233333333333332,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.0053,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Dostarlimab is a humanized IgG4 monoclonal antibody targeting programmed death receptor-1 (PD-1). It is used as an immune checkpoint inhibitor in the treatment of mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) endometrial cancer and is approved for use in certain advanced solid tumors.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult patients with advanced solid tumors, including endometrial cancer, based on population PK analyses.</p><h4>References</h4><ol><li><p>Patnaik, A, et al., &amp; Sachdev, JC (2022). Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial. <i>Cancer chemotherapy and pharmacology</i> 89(1) 93–103. DOI:<a href=&quot;https://doi.org/10.1007/s00280-021-04358-3&quot;>10.1007/s00280-021-04358-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34750637/&quot;>https://pubmed.ncbi.nlm.nih.gov/34750637</a></p></li><li><p>Baranda, JC, et al., &amp; Hodi, FS (2024). Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study. <i>Clinical and translational science</i> 17(6) e13854–None. DOI:<a href=&quot;https://doi.org/10.1111/cts.13854&quot;>10.1111/cts.13854</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38898592/&quot;>https://pubmed.ncbi.nlm.nih.gov/38898592</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end L01FF07;
